Suppr超能文献

早期多发性硬化症病变中胶质细胞增殖的鉴定

Identification of glial cell proliferation in early multiple sclerosis lesions.

作者信息

Schönrock L M, Kuhlmann T, Adler S, Bitsch A, Brück W

机构信息

Department of Neuropathology, University of Göttingen, Germany.

出版信息

Neuropathol Appl Neurobiol. 1998 Aug;24(4):320-30. doi: 10.1046/j.1365-2990.1998.00131.x.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system which leads to destruction of myelin sheaths. The patterns of cell proliferation in the early course of the disease are largely unknown. The present study used immunohistochemical identification of proliferating glial cells in stereotactic brain biopsy material of eight patients with early chronic MS. Double-labelling with the proliferation marker MIB-1 detected proliferating oligodendrocytes (MOG), astrocytes (GFAP) and microglia/macrophages (Ki-M1P). The majority of proliferating cells were macrophages/microglia when compared with oligodendrocytes (P > 0.005) or astrocytes (P > 0.0005); only a minor proportion of microglia/macrophages, however, proliferated in situ. Astrocytic and oligodendroglial proliferation was sparse to absent and showed significant variations between different patients. There were statistically significant differences when comparing the amount of proliferation between lesions of different demyelinating activity: highest numbers of proliferating cells were found in early active lesions compared with demyelinated and early remyelinated lesions (P > 0.05) or the periplaque white matter (P > 0.01). MOG-positive oligodendrocytes proliferated occasionally in the early stages of lesion formation; this proliferation occurred in four cases but was independent of the stage of the disease. Since MOG is expressed by mature oligodendrocytes, and not by immature precursors, this might suggest a potential role for the proliferation of mature surviving oligodendrocytes with subsequent remyelination.

摘要

多发性硬化症(MS)是一种中枢神经系统的慢性炎症性疾病,可导致髓鞘破坏。该疾病早期的细胞增殖模式在很大程度上尚不清楚。本研究采用免疫组织化学方法,对8例早期慢性MS患者立体定向脑活检材料中的增殖神经胶质细胞进行鉴定。用增殖标记物MIB-1进行双重标记,检测到增殖的少突胶质细胞(MOG)、星形胶质细胞(GFAP)和小胶质细胞/巨噬细胞(Ki-M1P)。与少突胶质细胞(P>0.005)或星形胶质细胞(P>0.0005)相比,大多数增殖细胞是巨噬细胞/小胶质细胞;然而,只有一小部分小胶质细胞/巨噬细胞在原位增殖。星形胶质细胞和少突胶质细胞的增殖稀疏或不存在,且不同患者之间存在显著差异。比较不同脱髓鞘活性病变之间的增殖量时,存在统计学显著差异:与脱髓鞘和早期再髓鞘化病变(P>0.05)或斑块周围白质(P>0.01)相比,早期活动性病变中增殖细胞数量最多。MOG阳性少突胶质细胞在病变形成早期偶尔增殖;这种增殖发生在4例患者中,但与疾病阶段无关。由于MOG由成熟少突胶质细胞表达,而非未成熟前体细胞表达,这可能提示成熟存活少突胶质细胞增殖并随后进行再髓鞘化具有潜在作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验